News
Hikma delivers strong performance in 2020
News
Hikma donates over $4 million USD in medicines and signs new long-term partnerships with Dispensary of Hope, Direct Relief, Americares, Brother’s Brother Foundation, and the National Children’s Cancer Society
News
Hikma launches Thiamine Hydrochloride Injection, USP
Preliminary 2020 Results
Watch our CEO Siggi Olafsson summarise our 2020 full year results
#OwnYour Career @Hikma
Our Analytical Research Manager, Rita tells us about her job and what excites her the most about her role.
Case study
Our support and impact; improving patient’s access to ritonavir
Insight
Kept out of reach - tackling the enduring challenge of access to medicine
Update
Hikma update regarding COVID-19
Find out more
Who we are. We make high quality medicines and make them accessible to the people that need them.
News
Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA
Find out more
Our commitment to sustainability
Find out more
We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.